18 06, 2024 Major Advances in SARS-CoV-2 Research and Therapeutics from CoVaRR-Net’s Pillar 3 Virology Team Neal Evan Caminsky2024-06-19T09:07:27-04:00June 18, 2024|Pillar 3, Hot Topic|
13 05, 2024 Germicidal efficacy of continuous and pulsed ultraviolet-C radiation on pathogen models and SARS-CoV-2 Neal Evan Caminsky2024-05-13T10:02:41-04:00May 13, 2024|Funded Research Results, Pillar 3|
2 05, 2024 Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions Neal Evan Caminsky2024-05-02T15:52:12-04:00May 2, 2024|Funded Research Results, Pillar 3|
19 02, 2024 SARS-CoV-2 rapidly evolves lineage-specific phenotypic differences when passaged repeatedly in immune-naïve mice Neal Evan Caminsky2024-04-24T14:47:51-04:00February 19, 2024|Funded Research Results, Pillar 3, Pillar 5|
21 08, 2023 The metallodrug BOLD-100 is a potent inhibitor of SARS-CoV-2 replication and has broad-acting antiviral activity Neal Evan Caminsky2023-08-21T09:32:06-04:00August 21, 2023|Funded Research Results, Pillar 3|
27 06, 2023 Nanoplasmonic amplification in microfluidics enables accelerated colorimetric quantification of nucleic acid biomarkers from pathogens Neal Evan Caminsky2023-06-27T11:46:21-04:00June 27, 2023|Funded Research Results, Pillar 3|
17 03, 2023 SARS-CoV-2 Nsp2 contributes to inflammation by activating NF-kB Neal Evan Caminsky2023-03-17T09:37:00-04:00March 17, 2023|Funded Research Results, Pillar 3|
17 03, 2023 Natural evolution of SARS-CoV-2 variants in K18-ACE2 mice gives rise to more virulent virus and variant alleles associated with treatment resistance Neal Evan Caminsky2023-03-17T09:32:07-04:00March 17, 2023|Funded Research Results, Pillar 3|
27 01, 2023 Nsp1 proteins of human coronaviruses HCoV-OC43 and SARS-CoV2 inhibit stress granule formation Neal Evan Caminsky2023-01-27T15:58:35-05:00January 27, 2023|Funded Research Results, Pillar 3|
7 11, 2022 Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants Neal Evan Caminsky2022-11-22T18:37:06-05:00November 7, 2022|Funded Research Results, Pillar 3|
